Hyperfine (HYPR) Gross Margin (2021 - 2026)

Hyperfine (HYPR) posted Gross Margin of 50.7% for Q1 2026, little changed on a QoQ basis from 50.9% in Q4 2025, and up 938.0% year-over-year from 4.88% in Q1 2025.

Hyperfine (HYPR) Gross Margin (2021 - 2026) Analysis & Trends

Hyperfine's Gross Margin history runs 6 years deep, the most recent figure standing at 50.7% for Q1 2026.

  • Quarterly Gross Margin rose 938.0% year-over-year to 50.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51.2% (up 501.0% YoY) and the FY2025 annual result came in at 49.79%, up 409.0% from the prior year.
  • Gross Margin was 50.7% for Q1 2026 at Hyperfine, roughly flat from 50.9% in the prior quarter.
  • Across five years, Gross Margin topped out at 53.77% in Q3 2025 and bottomed at 10.76% in Q2 2022.
  • A 5-year average of 37.83% and a median of 42.71% in 2023 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2022 — Gross Margin surged 12497 bps — and 2024, when it plunged 291 bps.
  • Hyperfine's Gross Margin stood at 21.07% in 2022, then surged by 83 bps to 38.5% in 2023, then dropped by 8 bps to 35.59% in 2024, then jumped by 43 bps to 50.9% in 2025, then declined by 0 bps to 50.7% in 2026.
  • Business Quant data shows HYPR's Gross Margin at 50.7% in Q1 2026, 50.9% in Q4 2025, and 53.77% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 56.20%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 63.29%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 65.35%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 78.01%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 62.95%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 45.22%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 38.53%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn 50.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 50.70%
Dec 31, 2025 50.90%
Sep 30, 2025 53.77%
Jun 30, 2025 49.26%
Mar 31, 2025 41.32%
Dec 31, 2024 35.59%
Sep 30, 2024 52.37%
Jun 30, 2024 49.66%
Mar 31, 2024 41.09%
Dec 31, 2023 38.50%
Sep 30, 2023 48.24%
Jun 30, 2023 42.71%
Mar 31, 2023 43.83%
Dec 31, 2022 21.07%
Sep 30, 2022 29.30%
Jun 30, 2022 -10.76%
Mar 31, 2022 5.57%
Dec 31, 2021 -103.90%
Sep 30, 2021 -91.11%
Jun 30, 2021 -27.65%